Literature DB >> 10332031

Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis.

A Sato1, T Shimohata, R Koide, H Takano, T Sato, M Oyake, S Igarashi, K Tanaka, T Inuzuka, H Nawa, S Tsuji.   

Abstract

To investigate the molecular mechanisms of neurodegeneration caused by expanded CAG repeats in dentatorubral-pallidoluysian atrophy (DRPLA), an autosomal dominant neuro degrees enerative disorder caused by unstable expansion of a CAG trinucleotide repeat in the DRPLA gene on 12p13.31, we established an efficient expression system for truncated and full-length DRPLA proteins with normal or expanded polyglutamine stretches in neuronally differentiated PC12 cells and fibroblasts using an adenovirus expression system. Although aggregate body formation was observed both in neuronally differentiated PC12 cells and in fibroblasts expressing truncated DRPLA proteins with Q82, >97% ( n = 3) of neuronally differentiated PC12 cells showed intra-nuclear inclusions, while only 31 21% ( n = 3) of fibro-blasts had intranuclear inclusions at 3 days after infection. The percentage of apoptotic cells was significantly higher in neuronally differentiated PC12 cells expressing the truncated DRPLA protein with Q82 than in fibroblasts, suggesting the possibility that intranuclear aggregate bodies are formed preferentially in neuronally differentiated PC12 cells and that these cells are more vulnerable than fibroblasts to the toxic effects of expanded polyglutamine stretches in the DRPLA protein. When the full-length DRPLA protein with Q82 was expressed, aggregate bodies were found exclusively in the nuclei of the neuronally differentiated PC12 cells, while they were found in the cytoplasm of fibroblasts. Despite the presence of aggregate bodies, apoptosis was not induced by expression of the full-length DRPLA protein with Q82 in either neuronally differentiated PC12 cells or fibroblasts, suggesting that the presence of intranuclear aggregate bodies is in itself not necessarily toxic to cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332031     DOI: 10.1093/hmg/8.6.997

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

Review 1.  Neuronal survival in epilepsy: to die or not to die?

Authors:  Subramaniam Ganesh; Shweta Singh
Journal:  J Biosci       Date:  2005-12       Impact factor: 1.826

2.  Intracellular green fluorescent protein-polyalanine aggregates are associated with cell death.

Authors:  J Rankin; A Wyttenbach; D C Rubinsztein
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

3.  Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.

Authors:  A Wyttenbach; J Carmichael; J Swartz; R A Furlong; Y Narain; J Rankin; D C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease.

Authors:  J Carmichael; J Chatellier; A Woolfson; C Milstein; A R Fersht; D C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 5.  The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.

Authors:  R Walsh; E Storey; D Stefani; L Kelly; V Turnbull
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia.

Authors:  Takashi Torashima; Chiho Koyama; Akira Iizuka; Kazuhiro Mitsumura; Kiyohiko Takayama; Shigeru Yanagi; Miho Oue; Haruyasu Yamaguchi; Hirokazu Hirai
Journal:  EMBO Rep       Date:  2008-03-14       Impact factor: 8.807

Review 7.  Running 'LAPS' Around nLD: Nuclear Lipid Droplet Form and Function.

Authors:  Michael J McPhee; Jayme Salsman; Jason Foster; Jordan Thompson; Sabateeshan Mathavarajah; Graham Dellaire; Neale D Ridgway
Journal:  Front Cell Dev Biol       Date:  2022-02-01

Review 8.  A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.

Authors:  Sean L Johnson; Wei-Ling Tsou; Matthew V Prifti; Autumn L Harris; Sokol V Todi
Journal:  Front Mol Neurosci       Date:  2022-09-14       Impact factor: 6.261

9.  Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice.

Authors:  Toshiya Sato; Masami Miura; Mitsunori Yamada; Takayuki Yoshida; Jonathan D Wood; Ikuru Yazawa; Masao Masuda; Takeo Suzuki; Ryong-Moon Shin; Hau-Jie Yau; Fu-Chin Liu; Takayoshi Shimohata; Osamu Onodera; Christopher A Ross; Motoya Katsuki; Hitoshi Takahashi; Masanobu Kano; Toshihiko Aosaki; Shoji Tsuji
Journal:  Hum Mol Genet       Date:  2008-11-27       Impact factor: 6.150

10.  A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.

Authors:  Qingyu Qin; Ryoko Inatome; Azusa Hotta; Masaki Kojima; Hirohei Yamamura; Hirokazu Hirai; Toshihiro Yoshizawa; Hirofumi Tanaka; Kiyoko Fukami; Shigeru Yanagi
Journal:  J Cell Biol       Date:  2006-02-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.